Signe Lenora Risumlund

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 173 citations · Full text

Medicine, Oncology, Perioperative Medicine +16

Interfractional dose accumulation for MR-guided liver SBRT: Variation among algorithms is highly patient- and fraction-dependent

Isak Wahlstedt, Abraham George Smith, C.E. Andersen et al. · Radiotherapy and Oncology · 2022 · 15 citations · Full text

Medicine, Radiation Oncology, Radiology +14

High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten et al. · Journal of Thoracic Oncology · 2025 · 11 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study

Dennis Tideman Arp, Ane Appelt, Lars Henrik Jensen et al. · Physica Medica · 2024 · 10 citations · Full text

Medicine, Oncology, Radiation Oncology +17